✦ LIBER ✦

Hyperthermia as an adjunct to radiation therapy in the treatment of superficially located malignancies: final results of a randomized trial of 2 vs. 6 hyperthermia treatments

✍ Scribed by Daniel S. Kapp; Ivy A. Petersen; Richard S. Cox; George M. Hahn; Peter Fessenden; Stavros D. Prionas; Eric R. Lee; Thaddeus V. Samulski; Malcolm A. Bagshaw

Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 131 KB
Volume: 17
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(89)90799-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin C as an adjunct to postoperati

Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck; results from a randomized clinical trial

✍ J.J. Fischer; B.G Haffty; Y.H. Son; D. Fischer; C.T Sasaki; R Papac; S Rockwell; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Interim results of a randomized trial of

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

✍ Kenneth B. Roberts; Nelson Urdaneta; Raul Vera; Andres Vera; Enrique Gutierrez; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 380 KB 👁 3 views

The purpose of this study was to determine the efficacy of mitomycin C as an adjunct to radiotherapy for the treatment of locally advanced cervix cancer. Patients with squamous-cell carcinoma of the cervix, stages IB2-IVA, were randomized to receive radiotherapy alone or radiotherapy with concomitan

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l